Vlastimil Valek
Overview
Explore the profile of Vlastimil Valek including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
35
Citations
363
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pavlik T, Jarkovsky J, Sanca O, Koziar Vasakova M, Dlouhy P, Cerny V, et al.
Open Forum Infect Dis
. 2024 Dec;
11(12):ofae685.
PMID: 39660016
Background: We examined the clinical effectiveness of molnupiravir in reducing deaths in a real-world cohort of adult patients with COVID-19 during the Omicron outbreak. Methods: This was a population-wide retrospective...
2.
Juza T, Valek V, Vlk D, Dostal M, Andrasina T
Eur J Radiol Open
. 2024 Jun;
12:100575.
PMID: 38882633
Purpose: To demonstrate advantages of spectral dual-layer computed tomography (CT) in diagnosing pulmonary embolism (PE). To compare D-dimer values in patients with PE and concomitant COVID-19 pneumonia to those in...
3.
Majek O, Babjuk M, Roobol M, Bratt O, van Poppel H, Zachoval R, et al.
Eur Urol Open Sci
. 2023 Jul;
53:106-108.
PMID: 37441346
Patient Summary: Prostate cancer is among the most frequent cancers and is one of the most common causes of cancer death among men. The European Union has recommended new pilot...
4.
Hajkova M, Andrasina T, Ovesna P, Rohan T, Dostal M, Valek V, et al.
In Vivo
. 2022 Sep;
36(5):2332-2341.
PMID: 36099102
Background/aim: To evaluate the prognostic value of Response Evaluation Criteria In Solid Tumors (RECIST), modified RECIST and volumetric analysis in patients with hepatocellular carcinoma (HCC) treated by transarterial chemoembolization (TACE)....
5.
Petrasova H, Slaisova R, Rohan T, Stary K, Kyclova J, Pavlik T, et al.
Contrast Media Mol Imaging
. 2022 May;
2022:8229445.
PMID: 35542754
Objectives: To extend and revise the diagnostic value of contrast-enhanced ultrasonography (CEUS) for differentiation between malignant and benign thyroid nodules. Methods: This single-institution prospective study aims to compare CEUS qualitative...
6.
Valek Jr V, Valek V, Uher M
Vnitr Lek
. 2022 Apr;
67(E-5):13-16.
PMID: 35459387
Aim: The analysis of the correlation between D-dimer and positive finding of pulmonary embolism on CT-angiography. Determination of the cut-off value of D-dimers, which would lead to a reduction in...
7.
Rohan T, Andrasina T, Matkulcik P, Bernard V, Valek V
Cardiovasc Intervent Radiol
. 2022 Feb;
45(6):873-878.
PMID: 35217890
Purpose: To prove feasibility and safety of percutaneous endoluminal radiofrequency ablation (eRFA) using a monopolar approach in treatment of occluded biliary stent in malignancy. Materials And Methods: The study included...
8.
Andrasina T, Rohan T, Panek J, Kovalcikova P, Kunovsky L, Ostrizkova L, et al.
Eur J Radiol
. 2022 Feb;
148:110180.
PMID: 35114534
No abstract available.
9.
Andrasina T, Rohan T, Panek J, Kovalcikova P, Kunovsky L, Ostrizkova L, et al.
Eur J Radiol
. 2021 Jul;
142:109830.
PMID: 34230002
Purpose: To analyse whether endobiliary radiofrequency ablation prior metal stent insertion in malignant biliary stenosis show improved survival or stent patency. Methods: 76 patients with histologically proven malignant biliary stenosis...
10.
Prognostic Survival Factors of Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
Rohan T, Uher M, Matkulcik P, Zavadil J, Ostrizkova L, Kiss I, et al.
Klin Onkol
. 2020 Jul;
33(3):214-219.
PMID: 32683878
Purpose: Identification of prognostic survival factors of hepatocellular carcinoma (HCC) treated with transarterial chemoembolization (TACE) in a single center in 2005-2018. Background: Transarterial chemoembolization in hepatocellular carcinoma is indicated in...